Home/ Stocks/ ACHV

Achieve Life Sciences, Inc.

ACHV XNAS

$2.90 -0.95 (-23.46%) ▼ 15-min delayed

Open

$3.66

High

$3.74

Low

$2.85

Volume

4.40M

Market Cap

$215.60M

About Achieve Life Sciences, Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Sector: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES Employees: 25 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2025	N/A	$-14,441,000	$-0.28
Q2 2025	N/A	$-12,718,000	$-0.37
Q1 2025	N/A	$-12,827,000	$-0.37
FY 2024	N/A	$-39,827,000	$-1.24

Related Market News

No specific coverage for ACHV yet. Check out our latest market news or earnings calendar.

Get ACHV Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Achieve Life Sciences, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.